BCDA•benzinga•
BioCardia Completes Low Dose Cohort Enrollment For CardiALLO Phase I/II Clinical Trial Of BCDA-03 Allogeneic Mesenchymal Stem Cells
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 13, 2025 by benzinga